SIMBIOTIC SOFTWARE, INC – Trademark Portfolio
Entity Type: 03
SIMBIOTIC SOFTWARE, INC holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include SIMBIO, SIMUTEXT, ECOBEAKER, EVOBEAKER, and OSMOBEAKER. The owner is based in MISSOULA, MT.
1280 S 3RD ST W, SECOND FLOOR, SUITE 3
MISSOULA, MT 59801
Showing of trademarks Trademarks
Trademark Classifications
SIMBIOTIC SOFTWARE, INC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SIMBIOTIC SOFTWARE, INC have?
SIMBIOTIC SOFTWARE, INC has 13 U.S. trademarks filed with the USPTO. Of these, 12 registered, 1 cancelled.
What trademark classes does SIMBIOTIC SOFTWARE, INC file in?
SIMBIOTIC SOFTWARE, INC files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are SIMBIOTIC SOFTWARE, INC's most well-known trademarks?
SIMBIOTIC SOFTWARE, INC's registered trademark portfolio includes well-known marks such as SIMBIO, SIMUTEXT, ECOBEAKER, EVOBEAKER, and OSMOBEAKER. These are among 12 currently registered trademarks in the portfolio.
What is SIMBIOTIC SOFTWARE, INC's trademark registration success rate?
SIMBIOTIC SOFTWARE, INC has a 92% trademark registration rate, with 12 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.